Quintana, Francisco

Vice-President

11 Settembre 2018
553 Views
Francisco J. Quintana, PhD
Professor of Neurology
Ann Romney Center for Neurologic Diseases
Brigham and Women’s Hospital
Harvard Medical School
Associate Member,
The Broad Institute of Harvard and MIT

Francisco J. Quintana, PhD is an Associate Professor of Neurology at the Center for Neurologic Diseases, at Brigham and Women’s Hospital, Harvard Medical School, and an Associate Member at the Broad Institute of Harvard and MIT.

 

Dr. Quintana, a graduate of the University of Buenos Aires (1999, Argentina), obtained his PhD in immunology at the Weizmann Institute of Science (2004, Israel).  He received postdoctoral training at the Weizmann Institute of Science and at Harvard Medical School.  In 2009, Dr. Quintana joined the faculty of Harvard Medical School.

Dr. Quintana’s research investigates signaling pathways that control the immune response and neurodegeneration, with the ultimate goal of identifying novel therapeutic targets and biomarkers for immune-mediated disorders.  Dr. Quintana has published over 150 peer reviewed articles and book chapters.  Dr. Quintana’s work identified an important role for the transcription factor AHR in the control of inflammation driven by adaptive and innate immune cells. His work has also identified important mechanisms that control neurodegeneration driven by CNS resident cells. In addition, Dr. Quintana’s research has resulted in multiple patents which have been the foundation of three companies: ImmunArray Ltd, Alma Bio Therapeutics and AnTolRx Inc.

Dr. Quintana is the recipient of the Lady Anne Chain Prize for Academic Excellence and Scientific Achievements, the Junior Investigator Award from the National Multiple Sclerosis Society, the Pathway to Independence Award of the National Institute of Allergy and Infectious Diseases, the Award for Outstanding Research Achievement form Nature Biotechnology, the Tecan Award for Innovation, the Harry Weaver Award from the National Multiple Sclerosis Society, the Mentor Award from Harvard Medical School, the Milestones in Multiple Sclerosis Research Award from the National Multiple Sclerosis Society and the AAI-BD Biosciences Investigator Award.

You may be interested

ESNI – Amsterdam 2019
News
5275 views
News
5275 views

ESNI – Amsterdam 2019

stine - 7 Febbraio 2019

17th European School of Neuroimmunology

ASNI – Montreal 2019
News
4143 views
News
4143 views

ASNI – Montreal 2019

stine - 5 Febbraio 2019

3rd Americas School of Neuroimmunology

Save the Date
News
382 views
News
382 views

Save the Date

stine - 4 Febbraio 2019

Nature and Ospedale San Raffaele is presenting congress in Advanced Cell Therapies and Tissue Engineering The congress will be held…